Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report.

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma and comprises approximately 30% of all lymphomas. Patients typically present with a nonpainful mass in the neck, groin, or abdomen associated with constitutional symptoms. In this report, however, the authors describe a rare case of a 61-year-old woman with hyperprolactinemia, hypothyroidism, and acromegaly (elevation of insulin-like growth factor-1 [IGF-1]) with elevated growth hormone-releasing hormone (GHRH) in whom an MRI demonstrated diffuse enlargement of the pituitary gland. Despite medical treatment, the patient had persistent elevation of IGF-1. She underwent a transsphenoidal biopsy, which yielded a diagnosis of DLBCL with an activated B-cell immunophenotype with somatotroph hyperplasia. After stereo-tactic radiation therapy in combination with chemotherapy, she is currently in remission from her lymphoma and has normalized IGF-1 levels without medical therapy, 8 months after her histopathological diagnosis. This is the only reported case of its kind and displays the importance of a broad differential diagnosis, multidisciplinary evaluation, and critical intraoperative decision-making when treating atypical sellar lesions.

[1]  A. Schally,et al.  Potentiating effects of GHRH analogs on the response to chemotherapy , 2015, Cell cycle.

[2]  G. Ehninger,et al.  Diabetes insipidus in a patient with a highly malignant B-cell lymphoma and stomatitis. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[3]  B. Coiffier,et al.  Maintenance therapy in diffuse large B-cell lymphoma , 2012, Current opinion in oncology.

[4]  J. H. Martínez,et al.  The Coexistence of an Intrasellar Adenoma, Lymphocytic Hypophysitis, and Primary Pituitary Lymphoma in a Patient with Acromegaly , 2011, Case reports in endocrinology.

[5]  B. Ramsahoye,et al.  Angiocentric T‐cell lymphoma associated with diabetes insipidus , 2009, European journal of haematology.

[6]  Markus Loeffler,et al.  Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). , 2008, The Lancet. Oncology.

[7]  R. Gascoyne,et al.  Clinical Trials and Observations , 2005 .

[8]  Randy D Gascoyne,et al.  Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. López-Guillermo,et al.  CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. , 2006, The Lancet. Oncology.

[10]  R. Gascoyne,et al.  Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Shereen Ezzat,et al.  The prevalence of pituitary adenomas , 2004, Cancer.

[12]  B. E. C. Oiffier,et al.  CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma , 2002 .

[13]  A. Khandji,et al.  Pituitary lymphoma presenting as fever of unknown origin. , 2001, The Journal of clinical endocrinology and metabolism.

[14]  P. Lichter,et al.  Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. , 2000, The New England journal of medicine.

[15]  K. Kovacs,et al.  Pituitary Lymphoma: A Case Report and Literature Review , 2000, Pituitary.

[16]  W. Au,et al.  Diffuse large‐cell B‐cell lymphoma in a pituitary adenoma: An unusual cause of pituitary apoplexy , 2000, American journal of hematology.

[17]  B. George,et al.  Unusual extra-axial central nervous system involvement of non-Hodgkin's lymphoma: magnetic resonance imaging. , 2000, Australasian radiology.

[18]  M. Matsuda,et al.  [A case of non-Hodgkin lymphoma in the central nervous system, developing during treatment of galactorrhea amenorrhea syndrome]. , 1999, Rinsho shinkeigaku = Clinical neurology.

[19]  R. Mirimanoff,et al.  Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. , 1999, Medicine.

[20]  A. Maiolo,et al.  Hypophyseal Non-Hodgkin's Lymphoma Presenting with Diabetes Insipidus: A Case Report , 1999, Journal of Neuro-Oncology.

[21]  M. Buchfelder,et al.  Intrasellar malignant lymphoma developing within pituitary adenoma , 1999, Acta Neuropathologica.

[22]  P. Freda,et al.  Differential diagnosis of sellar masses. , 1999, Endocrinology and metabolism clinics of North America.

[23]  C. Cockram,et al.  ADRENAL AND HYPOPHYSEAL NON‐HODGKIN'S LYMPHOMA PRESENTING WITH PANHYPOPITUITARISM , 1998, International journal of clinical practice.

[24]  A. Freemont,et al.  Angiotropic lymphoma with endocrine involvement , 1997, Histopathology.

[25]  B. Nathwani,et al.  A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .

[26]  F. Strachan,et al.  Non-Hodgkin Lymphoma with Panhypopituitarism, Hyperprolactinaemia and Sixth Nerve Palsy , 1997, Journal of the Royal Society of Medicine.

[27]  P. Wiernik,et al.  Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease. , 1997, Medical and pediatric oncology.

[28]  T. Oury,et al.  Lymphoma of the pituitary gland: an unusual presentation of central nervous system lymphoma in AIDS. , 1996, The American journal of medicine.

[29]  Martin A. Samuels,et al.  Case 36-1994 , 1994 .

[30]  J. Heimans,et al.  Hypophyseal Non-Hodgkin's Lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy , 1993, Journal of Neuro-Oncology.

[31]  Mahapatra Ak,et al.  Sellar-suprasellar primary malignant lymphoma: case report. , 1993 .

[32]  M. Shimoda,et al.  [A case of bilateral panophthalmoplegia caused by paranasal malignant lymphoma extending into the skull base]. , 1992, No shinkei geka. Neurological surgery.

[33]  L. Yu-Lee,et al.  Prolactin receptor gene expression in lymphoid cells , 1991, Molecular and Cellular Endocrinology.

[34]  P. Burger,et al.  Increasing incidence of primary brain lymphoma in the US , 1988, Cancer.

[35]  Douglas C. Miller,et al.  Primary central nervous system lymphoma. , 1988, Journal of neurosurgery.

[36]  L. Rose,et al.  Panhypopituitarism resulting from hodgkin's disease of the nasopharynx , 1978 .

[37]  L. Craver,et al.  LYMPHOSARCOMA: A REVIEW OF 1269 CASES , 1961, Medicine.

[38]  K. Miyazaki Treatment of Diffuse Large B-Cell Lymphoma. , 2016, Journal of clinical and experimental hematopathology : JCEH.

[39]  E. Jaffe,et al.  The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. , 2009, Hematology. American Society of Hematology. Education Program.

[40]  Hitoshi Takahashi,et al.  Intracranial malignant lymphomas: clinicopathological study of 26 autopsy cases , 2006, Brain Tumor Pathology.

[41]  H. Sekino,et al.  [A case of sellar T cell type malignant lymphoma]. , 1998, No shinkei geka. Neurological surgery.

[42]  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-1994. A 49-year-old man with hypopituitarism, multifocal neurologic defects, and an intracranial mass. , 1994, The New England journal of medicine.

[43]  E. Buchmann,et al.  [The hypophysis and haemoblastoses]. , 1979, Zentralblatt fur Neurochirurgie.